These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 30598578)
1. Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives. Kang TW; Lim HK; Cha DI World J Gastroenterol; 2018 Dec; 24(47):5331-5337. PubMed ID: 30598578 [TBL] [Abstract][Full Text] [Related]
2. Locoregional therapy for hepatocellular carcinoma. Guimaraes M; Uflacker R Clin Liver Dis; 2011 May; 15(2):395-421, vii-x. PubMed ID: 21689621 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. Nault JC; Sutter O; Nahon P; Ganne-Carrié N; Séror O J Hepatol; 2018 Apr; 68(4):783-797. PubMed ID: 29031662 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe. Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Yamakado K J Vasc Interv Radiol; 2012 Dec; 23(12):1622-8. PubMed ID: 23177108 [TBL] [Abstract][Full Text] [Related]
5. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations]. Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041 [TBL] [Abstract][Full Text] [Related]
6. Thermal ablation for hepatocellular carcinoma: what's new in 2019. Zhu F; Rhim H Chin Clin Oncol; 2019 Dec; 8(6):58. PubMed ID: 31968982 [TBL] [Abstract][Full Text] [Related]
7. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma. Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054 [TBL] [Abstract][Full Text] [Related]
8. Advances in non-surgical management of primary liver cancer. Chen X; Liu HP; Li M; Qiao L World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032 [TBL] [Abstract][Full Text] [Related]
9. Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma. Yuan W; Yang MJ; Xu J; Yan ZP; Liu R; Qu XD; Wang JH; Qian S Technol Cancer Res Treat; 2018 Jan; 17():1533033818788529. PubMed ID: 30045673 [TBL] [Abstract][Full Text] [Related]
10. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. Inchingolo R; Posa A; Mariappan M; Spiliopoulos S World J Gastroenterol; 2019 Aug; 25(32):4614-4628. PubMed ID: 31528090 [TBL] [Abstract][Full Text] [Related]
11. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152 [TBL] [Abstract][Full Text] [Related]
12. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone. Kim JH; Kim PN; Won HJ; Shin YM AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154 [TBL] [Abstract][Full Text] [Related]
13. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261 [TBL] [Abstract][Full Text] [Related]
14. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036 [TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation for hepatocellular carcinoma. Nishikawa H; Kimura T; Kita R; Osaki Y Int J Hyperthermia; 2013 Sep; 29(6):558-68. PubMed ID: 23937321 [TBL] [Abstract][Full Text] [Related]
16. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma. Lee SY; Hyun D; Cho SK; Shin SW; Jung SH; Chi SA Cardiovasc Intervent Radiol; 2018 Jan; 41(1):120-129. PubMed ID: 28924943 [TBL] [Abstract][Full Text] [Related]
17. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Frühling P; Nilsson A; Duraj F; Haglund U; Norén A Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria. Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006 [TBL] [Abstract][Full Text] [Related]
19. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation. Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635 [TBL] [Abstract][Full Text] [Related]